Review
Published on 20 Oct 2022
Benefits of SGLT2 inhibitors in arrhythmias
in Cardiovascular Therapeutics
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1011429
- 10,355 views
- 36 citations
182 articles related to "Sglt2 Inhibitors"
Articles
Mini Review
Published on 19 Jan 2026
Benefits of SGLT2 inhibitors in patients with diabetes and advanced chronic kidney disease – where have we gone so far?
in Diabetes Nephropathy
Frontiers in Clinical Diabetes and Healthcare
doi 10.3389/fcdhc.2025.1759340
- 1,410 views
Review
Published on 08 Jan 2020
SGLT2 Inhibitors Play a Salutary Role in Heart Failure via Modulation of the Mitochondrial Function
in Cardiovascular Metabolism
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2019.00186
- 24,760 views
- 112 citations
Review
Published on 21 Oct 2021
Sodium–Glucose Cotransporter 2 Inhibitors Work as a “Regulator” of Autophagic Activity in Overnutrition Diseases
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.761842
- 8,029 views
- 31 citations
Review
Published on 28 Feb 2025
Effect of sodium-glucose Co-transporter 2 inhibitors on coronary microcirculation
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1523727
- 3,193 views
- 3 citations
Mini Review
Published on 08 Jan 2019
Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01517
- 19,370 views
- 78 citations
Review
Published on 23 Feb 2022
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.800490
- 25,211 views
- 87 citations
Review
Published on 30 Jan 2025
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
in Pediatric Nephrology
Frontiers in Pediatrics
doi 10.3389/fped.2025.1521425
- 8,321 views
- 4 citations
Perspective
Published on 23 Sep 2021
Is There a Diabetes–Kidney–Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors
in Cardiovascular Therapeutics
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2021.716083
- 5,892 views
- 2 citations
Original Research
Published on 08 Mar 2023
The impact of SGLT2 inhibitors on αKlotho in renal MDCK and HK-2 cells
in Renal Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1069715
- 6,869 views
- 9 citations
Systematic Review
Published on 13 Jun 2023
Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1145587
- 30,125 views
- 25 citations
Systematic Review
Published on 16 Aug 2021
Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis
in Obesity
Frontiers in Endocrinology
doi 10.3389/fendo.2021.706914
- 33,866 views
- 47 citations
Review
Published on 20 Dec 2022
Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1086672
- 5,769 views
- 12 citations
Mini Review
Published on 21 Sep 2022
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
in Cardiovascular Therapeutics
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1010693
- 24,247 views
- 77 citations
Review
Published on 10 Oct 2023
Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1215356
- 53,859 views
- 126 citations
Systematic Review
Published on 07 Feb 2023
Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis
in Heart Failure and Transplantation
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1046194
- 9,091 views
- 17 citations